93 related articles for article (PubMed ID: 12034920)
1. Paradigms of growth control: relation to Cdk activation.
Olashaw N; Pledger WJ
Sci STKE; 2002 May; 2002(134):re7. PubMed ID: 12034920
[TBL] [Abstract][Full Text] [Related]
2. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
Touyz RM; Yao G
J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
[TBL] [Abstract][Full Text] [Related]
3. p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.
Luedde T; Rodriguez ME; Tacke F; Xiong Y; Brenner DA; Trautwein C
Hepatology; 2003 Apr; 37(4):833-41. PubMed ID: 12668976
[TBL] [Abstract][Full Text] [Related]
4. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
[TBL] [Abstract][Full Text] [Related]
5. Efficient down-regulation of cyclin A-associated activity and expression in suspended primary keratinocytes requires p21(Cip1).
Hauser P; Ma L; Agrawal D; Haura E; Cress WD; Pledger WJ
Mol Cancer Res; 2004 Feb; 2(2):96-104. PubMed ID: 14985466
[TBL] [Abstract][Full Text] [Related]
6. Loss of p27(Kip1) cooperates with cyclin E in T-cell lymphomagenesis.
Geisen C; Karsunky H; Yücel R; Möröy T
Oncogene; 2003 Mar; 22(11):1724-9. PubMed ID: 12642875
[TBL] [Abstract][Full Text] [Related]
7. Removal of Cdk inhibitors through both sequestration and downregulation in zearalenone-treated MCF-7 breast cancer cells.
Ahamed S; Foster JS; Bukovsky A; Diehl JA; Wimalasena J
Mol Carcinog; 2002 May; 34(1):45-58. PubMed ID: 12112322
[TBL] [Abstract][Full Text] [Related]
8. CDK activation by non-cyclin proteins.
Nebreda AR
Curr Opin Cell Biol; 2006 Apr; 18(2):192-8. PubMed ID: 16488127
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
10. Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential.
Andrés V
Cardiovasc Res; 2004 Jul; 63(1):11-21. PubMed ID: 15194457
[TBL] [Abstract][Full Text] [Related]
11. Established and novel Cdk/cyclin complexes regulating the cell cycle and development.
Gopinathan L; Ratnacaram CK; Kaldis P
Results Probl Cell Differ; 2011; 53():365-89. PubMed ID: 21630153
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle regulation of the mammalian CDK activator RINGO/Speedy A.
Dinarina A; Santamaria PG; Nebreda AR
FEBS Lett; 2009 Sep; 583(17):2772-8. PubMed ID: 19622356
[TBL] [Abstract][Full Text] [Related]
13. The Ets transcription factor GABP is required for cell-cycle progression.
Yang ZF; Mott S; Rosmarin AG
Nat Cell Biol; 2007 Mar; 9(3):339-46. PubMed ID: 17277770
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanism of cell cycle blockage of hepatoma SK-Hep-1 cells by Epimedin C through suppression of mitogen-activated protein kinase activation and increased expression of CDK inhibitors p21(Cip1) and p27(Kip1).
Liu TZ; Chen CY; Yiin SJ; Chen CH; Cheng JT; Shih MK; Wang YS; Chern CL
Food Chem Toxicol; 2006 Feb; 44(2):227-35. PubMed ID: 16112786
[TBL] [Abstract][Full Text] [Related]
15. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.
Boehm M; Yoshimoto T; Crook MF; Nallamshetty S; True A; Nabel GJ; Nabel EG
EMBO J; 2002 Jul; 21(13):3390-401. PubMed ID: 12093740
[TBL] [Abstract][Full Text] [Related]
16. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
17. A novel function of benzyl isothiocyanate in vascular smooth muscle cells: the role of ERK1/2, cell cycle regulation, and matrix metalloproteinase-9.
Lee JY; Moon SK; Hwang CW; Nam KS; Kim YK; Yoon HD; Kim MG; Kim CH
J Cell Physiol; 2005 Jun; 203(3):493-500. PubMed ID: 15605368
[TBL] [Abstract][Full Text] [Related]
18. [Role of CDC25 phosphatases in the control of proliferation].
Davezac N; Ducommun B; Baldin V
Pathol Biol (Paris); 2000 Apr; 48(3):182-9. PubMed ID: 10858952
[TBL] [Abstract][Full Text] [Related]
19. Towards a blueprint of the cell cycle.
Alberghina L; Porro D; Cazzador L
Oncogene; 2001 Mar; 20(9):1128-34. PubMed ID: 11314050
[TBL] [Abstract][Full Text] [Related]
20. RINGO/Speedy proteins, a family of non-canonical activators of CDK1 and CDK2.
Gonzalez L; Nebreda AR
Semin Cell Dev Biol; 2020 Nov; 107():21-27. PubMed ID: 32317145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
